TENX
Tenax Therapeutics Inc
1.90$
+2.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.1% | 28.2% | 58.4% | 81.5% | 99.9% | 97.1% | 98.9% | 94.9% | 94.2% | 100.0% | 100.0% | 100.0% | |
| 62.4% | 5.0% | 42.8% | 16.2% | 92.7% | 77.1% | 91.0% | 93.2% | 62.4% | 83.8% | 98.1% | 93.6% | |
| 62.4% | 27.7% | 56.9% | 78.1% | 96.4% | 84.8% | 97.7% | 93.2% | 62.4% | 83.8% | 98.1% | 93.6% | |
| 0.1% | 0.1% | 0.3% | 0.5% | 0.0% | – | – | – | – | – | – | – | |
| 0.4% | 0.2% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.9% | 4.9% | – | – | – | – | |
| 12.1% | 15.4% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 24.6% | 30.1% | 94.3% | 0.0% | – | – | – | – | – | – | – | – | |
| 11.3% | 17.2% | 26.6% | 10.2% | 11.7% | 40.7% | 32.7% | 29.2% | 56.2% | 30.7% | 4.9% | 6.9% | |
| 2.8% | 6.3% | 26.6% | 10.2% | 11.7% | 39.8% | 30.8% | 26.1% | 54.3% | 30.7% | 4.9% | 6.9% | |
| 0.4% | 0.2% | – | – | – | 1.7% | 2.6% | 1.8% | 21.8% | 4.3% | – | – | |
| 0.4% | 1.3% | 3.1% | 6.2% | 5.6% | 26.1% | 11.0% | 14.3% | 13.2% | 17.7% | 3.3% | 5.8% | |
| 0.0% | – | 0.0% | 0.0% | – | – | 1.8% | – | – | – | – | – | |
| 88.7% | 82.8% | 73.4% | 89.8% | 88.3% | 59.3% | 67.3% | 70.8% | 43.8% | 69.3% | 95.1% | 93.1% | |
| -146.2% | -220.2% | -876.9% | -2,158.6% | -1,708.0% | -3,710.3% | -3,581.8% | -4,647.6% | -8,504.2% | -2,544.0% | -325.6% | -352.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.5% | 2.1% | 15.8% | 37.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.